Docoh
Loading...

AMAR Amarillo Biosciences

Amarillo Biosciences, Inc. (ABI) is a diversified healthcare company engaged in the discovery and development of pharmaceutical and biotech products. Our goal is to introduce novel products that actively stimulate and rejuvenate the human body to combat disease and enhance the ability to heal. We engage in the advancement of low-dose non-injectable interferon as a therapeutic treatment for numerous indications such as thrombocytopenia, Sjögren’s syndrome, hepatitis C virus (HCV) and influenza. ABI primarily operates through three divisions: Pharmaceutical, Medical and Consumer. The Pharmaceutical division leverages a proprietary library of over a hundred scientific and clinical data studies on various human and animal applications of low-dose interferon, for patent licensing and commercialization opportunities with global partners. The Medical division is focused on developing an innovative, state-of-the-art technology to treat metabolism related diseases such as Type 1 and Type 2 diabetes in Asia. The Consumer division includes a range of nutraceutical and food supplement products that utilize our unique liposomal delivery systems. ABI currently has offices in the United States and Taiwan.

Company profile

Ticker
AMAR
Exchange
Employees
Incorporated
Location
Fiscal year end
SEC CIK
IRS number
751974352

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

30 Mar 21
11 Apr 21
31 Dec 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 22.25K 22.25K 22.25K 22.25K 22.25K 22.25K
Cash burn (monthly) 20.51K 32.23K 147.6K 120.04K 30.39K 41.63K
Cash used (since last report) 69.16K 108.7K 497.77K 404.8K 102.49K 140.39K
Cash remaining -46.91K -86.46K -475.52K -382.56K -80.24K -118.14K
Runway (months of cash) -2.3 -2.7 -3.2 -3.2 -2.6 -2.8

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
12 Oct 20 Stephen T Chen Common Stock Buy Aquire P Yes No 0.14 400 56 783,000
9 Oct 20 Stephen T Chen Common Stock Buy Aquire P Yes No 0.13 100 13 782,600
9 Oct 20 Stephen T Chen Common Stock Buy Aquire P Yes No 0.14 200 28 782,500
8 Oct 20 Stephen T Chen Common Stock Buy Aquire P Yes No 0.13 400 52 782,300
5 Oct 20 Stephen T Chen Common Stock Buy Aquire P Yes No 0.22 200 44 781,900
28 Sep 20 Stephen T Chen Common Stock Buy Aquire P Yes No 0.18 300 54 781,700
22 Sep 20 Stephen T Chen Common Stock Buy Aquire P Yes No 0.2 200 40 781,400
21 Sep 20 Stephen T Chen Common Stock Buy Aquire P Yes No 0.16 800 128 781,200
17 Sep 20 Stephen T Chen Common Stock Buy Aquire P Yes No 0.22 100 22 780,400
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
7th grade Avg
New words: advisory, AFR, Antigen, antitrust, Appetite, bacterial, bound, brought, budget, carrier, case, casualty, Cayman, Central, CFR, charter, civil, classified, cleared, climate, column, contemplated, content, cooperate, Cooperative, coordination, corrupt, coverage, criminal, critical, cultural, customary, damage, decline, diagnostic, difficulty, digital, diminish, disbursed, disruption, distance, diversion, Efficiency, enforcement, entirety, evolving, exempt, EXH, expansion, export, expose, exposed, fabrication, foregoing, formal, formally, forty, fulfillment, geopolitical, hardware, Harm, Hartford, helicobacter, impede, inability, indemnification, Index, infection, infrastructure, inherently, injury, internet, invention, IRS, iv, John, joinder, jointly, judgment, Junyong, kit, labor, Lan, language, Leadtech, Leadtek, Licensor, loan, loaned, loaning, lodging, mailing, maintenance, media, MINE, modest, monetary, MOU, negligible, newer, nominated, notification, omitted, ordinary, Package, pandemic, PMA, pneumonia, policy, political, predecessor, predicate, premarket, privacy, profile, proportionate, prosecution, pylori, rapid, recoup, Release, rename, Repair, repatriation, reputation, resign, retroactive, retroactively, risky, Salary, scaling, Serial, Settlement, signified, similarly, situation, SMART, spent, staffing, stem, strain, sum, sustained, terrorism, text, threatened, tightening, track, transportation, Trustee, TWD, UHO, unanticipated, uncured, Unfavorable, unpredictable, unreasonable, unrounded, unscheduled, vacated, Vaccine, vaginal, vi, volume, wage, war, workforce, writing
Removed: accurate, adjusted, aggressively, ASU, August, bring, calculated, carried, checkmark, constituting, COSO, covered, criteria, declared, deficiency, demanded, detected, developer, dietary, direction, disability, dry, duty, ensuring, event, expended, external, fiduciary, fourth, hiring, illegality, instructed, insufficient, intend, interim, investor, knowledgeable, managed, Maxisal, minimize, modified, nanogram, patient, permanent, permit, pervasive, prevented, professionally, promised, proper, quarter, receiving, recognition, reliability, relief, remedy, restriction, resume, retrospective, room, satisfactory, segregation, shipped, size, small, suffering, sufficient, symptomatic, training, transferred, uncollectible, unique, utilized, voted